Edward W Lipkin1, Ann V Schwartz2, Andrea M Anderson3, Cralen Davis3, Karen C Johnson4, Edward W Gregg5, George A Bray6, Robert Berkowitz7, Anne L Peters8, Amelia Hodges3, Cora Lewis9, Steven E Kahn10. 1. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA ewl@u.washington.edu. 2. Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, CA. 3. Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC. 4. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN. 5. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA. 6. Pennington Biomedical Research Center of Louisiana State University, Baton Rouge, LA. 7. University of Pennsylvania School of Medicine, Philadelphia, PA. 8. Department of Medicine, Division of Endocrinology, Keck School of Medicine of University of Southern California, Los Angeles, CA. 9. Department of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL. 10. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA.
Abstract
OBJECTIVE: To determine whether an intensive lifestyle intervention (ILI) designed to sustain weight loss and improve physical fitness in overweight or obese persons with type 2 diabetes was associated with bone loss after 4 years of follow-up. RESEARCH DESIGN AND METHODS: This randomized controlled trial of intensive weight loss compared an ILI with a diabetes support and education (DSE) group among 1,309 overweight or obese subjects. Bone mineral density was assessed at baseline and after 1 year and 4 years of intervention. RESULTS: ILI was effective in producing significant weight loss (5.3% vs. 1.8% in ILI and DSE, respectively; P < 0.01) and increased fitness (6.4% vs. -0.8%) at year 4. In men, ILI participants had a greater rate of bone loss during the first year (-1.66% vs. -0.09% per year in ILI and DSE, respectively). Differences between groups were diminished by one-half after 4 years (-0.88% vs. -0.05% per year in ILI and DSE, respectively) but remained significant (P < 0.01). The difference in rate of hip bone loss between groups over 4 years was related to increased weight loss in ILI. Among women, the rate of bone loss did not differ between ILI and DSE after 4 years. CONCLUSIONS: A 4-year weight loss intervention was significantly associated with a modest increase in bone loss at the hip in men but not in women.
RCT Entities:
OBJECTIVE: To determine whether an intensive lifestyle intervention (ILI) designed to sustain weight loss and improve physical fitness in overweight or obesepersons with type 2 diabetes was associated with bone loss after 4 years of follow-up. RESEARCH DESIGN AND METHODS: This randomized controlled trial of intensive weight loss compared an ILI with a diabetes support and education (DSE) group among 1,309 overweight or obese subjects. Bone mineral density was assessed at baseline and after 1 year and 4 years of intervention. RESULTS: ILI was effective in producing significant weight loss (5.3% vs. 1.8% in ILI and DSE, respectively; P < 0.01) and increased fitness (6.4% vs. -0.8%) at year 4. In men, ILI participants had a greater rate of bone loss during the first year (-1.66% vs. -0.09% per year in ILI and DSE, respectively). Differences between groups were diminished by one-half after 4 years (-0.88% vs. -0.05% per year in ILI and DSE, respectively) but remained significant (P < 0.01). The difference in rate of hip bone loss between groups over 4 years was related to increased weight loss in ILI. Among women, the rate of bone loss did not differ between ILI and DSE after 4 years. CONCLUSIONS: A 4-year weight loss intervention was significantly associated with a modest increase in bone loss at the hip in men but not in women.
Authors: J C Rockwell; A M Sorensen; S Baker; D Leahey; J L Stock; J Michaels; D T Baran Journal: J Clin Endocrinol Metab Date: 1990-10 Impact factor: 5.958
Authors: Rocky Strollo; Andreea Soare; Yeganeh Manon Khazrai; Antonio Di Mauro; Andrea Palermo; Rossella Del Toro; Sara Fallucca; Maria Giovanna Belluomo; Laura Dugo; Mario Pianesi; Paolo Pozzilli; Nicola Napoli Journal: Endocrine Date: 2016-11-25 Impact factor: 3.633
Authors: Kristen M Beavers; Michael P Walkup; Ashley A Weaver; Leon Lenchik; Stephen B Kritchevsky; Barbara J Nicklas; Walter T Ambrosius; Joel D Stitzel; Thomas C Register; Sue A Shapses; Anthony P Marsh; W Jack Rejeski Journal: J Bone Miner Res Date: 2018-08-07 Impact factor: 6.741
Authors: Kristen M Beavers; Rebecca H Neiberg; Karen C Johnson; C Hunter Davis; Ramon Casanova; Ann V Schwartz; Carolyn J Crandall; Cora E Lewis; Xavier Pi-Sunyer; Stephen B Kritchevsky Journal: JBMR Plus Date: 2018-10-25
Authors: Karen C Johnson; George A Bray; Lawrence J Cheskin; Jeanne M Clark; Caitlin M Egan; John P Foreyt; Katelyn R Garcia; Stephen Glasser; Frank L Greenway; Edward W Gregg; Helen P Hazuda; Andrea Hergenroeder; James O Hill; Edward S Horton; John M Jakicic; Robert W Jeffery; Steven E Kahn; William C Knowler; Cora E Lewis; Marsha Miller; Maria G Montez; David M Nathan; Jennifer L Patricio; Anne L Peters; Xavier Pi-Sunyer; Henry J Pownall; David Reboussin; J Bruce Redmon; Helmut Steinberg; Thomas A Wadden; Lynne E Wagenknecht; Rena R Wing; Catherine R Womack; Susan Z Yanovski; Ping Zhang; Ann V Schwartz Journal: J Bone Miner Res Date: 2017-07-28 Impact factor: 6.741
Authors: Kylie A Simpson; Yorgi Mavros; Shelley Kay; Jacinda Meiklejohn; Nathan de Vos; Yi Wang; Qianyu Guo; Renru Zhao; Mike Climstein; Bernard T Baune; Steven Blair; Anthony J O'Sullivan; David Simar; Nalin Singh; Maria A Fiatarone Singh Journal: Trials Date: 2015-11-10 Impact factor: 2.279